[go: up one dir, main page]

MX9710260A - Isocromanos 1, 6-disustituidos para el tratamiento de migrañas. - Google Patents

Isocromanos 1, 6-disustituidos para el tratamiento de migrañas.

Info

Publication number
MX9710260A
MX9710260A MX9710260A MX9710260A MX9710260A MX 9710260 A MX9710260 A MX 9710260A MX 9710260 A MX9710260 A MX 9710260A MX 9710260 A MX9710260 A MX 9710260A MX 9710260 A MX9710260 A MX 9710260A
Authority
MX
Mexico
Prior art keywords
treatment
migrains
isocromanes
disstituted
useful
Prior art date
Application number
MX9710260A
Other languages
English (en)
Inventor
Michael D Ennis
Ruth E Tenbrink
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MX9710260A publication Critical patent/MX9710260A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invencion es el compuesto isocromano 1,6-disustituido de la formula (I), y aminas biciclicas aromáticas (ABA) que son utiles para el tratamiento de dolores de cabeza, en especial migraña y jaqueca y también son utiles como antipsicoticos y para el tratamiento de otros desordenes del sistema nervioso central y/o cardiovasculares como analgésicos.
MX9710260A 1995-06-30 1996-06-07 Isocromanos 1, 6-disustituidos para el tratamiento de migrañas. MX9710260A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US1123496P 1996-02-06 1996-02-06
PCT/US1996/008681 WO1997002259A1 (en) 1995-06-30 1996-06-07 1,6-disubstituted isochromans for treatment of migraine headaches

Publications (1)

Publication Number Publication Date
MX9710260A true MX9710260A (es) 1998-03-29

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9710260A MX9710260A (es) 1995-06-30 1996-06-07 Isocromanos 1, 6-disustituidos para el tratamiento de migrañas.

Country Status (12)

Country Link
EP (1) EP0836599A1 (es)
JP (1) JPH11509532A (es)
AU (1) AU6252296A (es)
BR (1) BR9609631A (es)
CA (1) CA2225282A1 (es)
CZ (1) CZ418597A3 (es)
FI (1) FI974640L (es)
MX (1) MX9710260A (es)
NO (1) NO976112L (es)
PL (1) PL324319A1 (es)
SK (1) SK164297A3 (es)
WO (1) WO1997002259A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
BRPI0510642A (pt) 2004-05-05 2007-11-20 Hoffmann La Roche arilsulfonil benzodioxanos úteis para modulação do receptor de 5-ht6, do receptor de 5ht2a ou ambos
CN101119989B (zh) 2004-12-21 2010-06-09 弗·哈夫曼-拉罗切有限公司 色满衍生物及其在治疗cns疾病中的用途
AU2005318596B2 (en) 2004-12-21 2010-12-23 F. Hoffmann-La Roche Ag Chroman derivatives and their use as 5-HT receptor ligands
ES2314749T3 (es) 2004-12-21 2009-03-16 F. Hoffmann-La Roche Ag Derivados de tetralina y de indano y usos de los mismos como antagonistas de 5-ht.
KR100899061B1 (ko) 2004-12-21 2009-05-25 에프. 호프만-라 로슈 아게 테트랄린 및 인단 유도체 및 이의 용도
PL1831159T3 (pl) 2004-12-21 2010-06-30 Hoffmann La Roche Pochodne tetraliny i indanu oraz ich zastosowania
RU2008115032A (ru) 2005-11-03 2009-12-10 Ф. Хоффманн-Ля Рош Аг (Ch) Арилсульфонилхроманы в качестве ингибиторов 5-нт6
EP2041079A1 (en) 2006-06-20 2009-04-01 F. Hoffmann-Roche AG Arylsulfonyl naphthalene derivatives and uses thereof
CA2655524A1 (en) 2006-06-20 2007-12-27 F. Hoffman-La Roche Ag Arylsulfonamidyl tetralin derivatives and uses thereof
AU2007263084A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN102341367B (zh) * 2009-03-05 2014-05-07 住友化学株式会社 卤素取代苯二甲醇的制造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
NZ277373A (en) * 1993-12-28 1998-07-28 Upjohn Co Iso(thio)chroman-1-ylethylpiperazine and -piperidine derivatives (analogues)

Also Published As

Publication number Publication date
NO976112D0 (no) 1997-12-29
FI974640A7 (fi) 1997-12-30
CZ418597A3 (cs) 1998-06-17
WO1997002259A1 (en) 1997-01-23
FI974640A0 (fi) 1997-12-30
FI974640L (fi) 1997-12-30
BR9609631A (pt) 1999-03-02
AU6252296A (en) 1997-02-05
SK164297A3 (en) 1998-09-09
CA2225282A1 (en) 1997-01-23
NO976112L (no) 1998-03-02
EP0836599A1 (en) 1998-04-22
PL324319A1 (en) 1998-05-25
JPH11509532A (ja) 1999-08-24

Similar Documents

Publication Publication Date Title
MX9710260A (es) Isocromanos 1, 6-disustituidos para el tratamiento de migrañas.
MX9304698A (es) Heterociclos que contienen nitrogeno substituido.
ES2133714T3 (es) Compuestos heterociclicos para el tratamiento de trastornos del snc y cardiovasculares.
ES2149888T3 (es) 3-(3,4-dioxifenil)-pirrolidinas como inhibidores de la fosfodiesterasa de tipo iv para el tratamiento de enfermedades inflamatorias.
ES2126122T3 (es) Nitrato-aminoacido-disulfuros para la terapia de enfermedades del sistema cardio-circulatorio.
ATE141785T1 (de) Zusammensetzung und methode zur verstärkung der sonnenbräunung
NO20000762D0 (no) Anvendelse av substituerte adeninderivater til behandling av multippel sklerose
ES2194960T3 (es) N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
MX9203050A (es) Compuestos de analogos de triptamina.
BR9712831A (pt) Inibidores tricìclicos de farnesil proteìna transferase
BR9712285A (pt) Tetrafosfonato bicìclico de trianidridas
FI905958A0 (fi) Foerfarande foer framstaellning av substituerade cyklohexanoler, som verkar pao det centrala nervsystemet.
ES2058306T3 (es) Tetralinas substituidas, cromanos y compuestos relacionados en el tratamiento del asma, artritis y enfermedades relacionadas.
EA200300807A1 (ru) Лечение нарушений центральной нервной системы с использованием антагонистов оксидазы d-аминокислот и d-аспартатоксидазы
CO4700426A1 (es) Ligandos especificos del neuropeptido y1
DE69703617D1 (de) Verwendung von optisch reines (+) norcisapride zur behandlung von erbrechen und zns-störungen
PA8457001A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol
HU9402933D0 (en) Neurotensine-receptor-active 1-naphtyl-pyrazol-3-carboxamides process for producing them and pharmaceutical compositions containing them as active components
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
ES2170798T3 (es) Benzopiranos y su uso como agentes terapeuticos.
ES2132401T3 (es) Tetrahidro-1h-benzazepinonas y hexahidroazepinonas como antagonistas selectivos del receptor colecistoquinina-b.
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos
ES2099865T3 (es) Ciclopentanoperhidrofenantreno-17beta-(3-furil)-3-derivados y composiciones farmaceuticas que comprenden los mismos para el tratamiento de trastornos cardiovasculares.
FI905957A0 (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
ES2061681T3 (es) Cromados sustituidos y compuestos relacionados en el tratamiento del asma.